Clinical research guide

For research education. This guide is not medical advice and does not offer treatment guidance or advice on human or animal use.

How to evaluate
peptide clinical research.

Learn how a study’s question, design and endpoint shape what its results can and cannot establish.

Read the guide Longevity evidence guide

A key point

What a trial can
and cannot show.

Every clinical study has a defined scope: molecule, formulation, protocol, population, comparator, endpoint and follow up. Its findings should be interpreted within those boundaries. [5][8]

A trial registry records a planned study. It does not establish that an intervention is safe, effective, authorised or suitable for public use. Early human studies often examine tolerability, pharmacology and exploratory signals. Larger studies may answer more specific questions, but results still apply only to the populations and endpoints studied. [4][5][6] For an example of a material specific entry, review the Retatrutide research record.

Four steps for reading a study

A practical way to assess
a clinical study.

Use these steps to distinguish a research question, trial label or individual result from the conclusions the evidence can support.

Start with the exact question

Read a study against its stated objective. Check the exact molecule, finished form, population, comparison and endpoint that the protocol was designed to examine. [4][5][8]

Identify the evidence stage

Studies in the laboratory, in animals and in people at different stages answer different questions. A positive result at one stage does not automatically apply to another. [4][5][6]

Separate endpoint from outcome

A molecular marker, laboratory measurement or short term study endpoint can be useful, but it does not automatically demonstrate a lasting clinical benefit or an effect on longevity. [5][7]

Check the study’s limits

Population, sample size, follow up, comparator, formulation and protocol determine what can reasonably be inferred. Results should not be extended beyond the study’s question. [5][6][8]

Protocol checklist

Check six details
before reading the result.

Abstracts are useful starting points, not complete study reports. These details clarify what was measured, who was studied and where uncertainty remains.

01
The exact molecule and the form supplied or studied
02
The study population and eligibility criteria
03
The comparison, control or background treatment
04
The primary endpoint and when it was measured
05
The sample size, follow up, withdrawals and adverse event reporting
06
Whether the finding has been replicated or evaluated by regulators for a defined use

Understanding endpoints

Mechanisms, markers and
clinical outcomes.

A mechanism explains the biological question researchers are investigating. A biomarker is a measured signal. A clinical endpoint measures a defined outcome in a specified study population. These categories are not interchangeable.

An apparent improvement in one measurement does not, on its own, establish a broader personal benefit, longer life, disease prevention, treatment effect or product suitability. [2][5][7]

Questions to consider

What clinical research
cannot answer alone.

Can a promising early study establish effectiveness?

No. Early phases can provide useful information about how a substance behaves in people, including tolerability, pharmacology and early signals, but do not by themselves establish lasting clinical benefit. [5][6]

Does an authorised product validate another material with the same name?

No. Authorisation applies to a specified finished product, formulation, dose, indication and manufacturer context. It does not establish equivalence for a separately listed material. [4][5]

Does study registration confirm a result?

No. Registration describes a protocol and research objective. Results, quality, interpretation, regulatory assessment and relevance to other settings need separate evaluation. [8]

Research use note: Use this guide to assess published research and trial records. It cannot determine a substance’s dose, administration, safety, suitability or therapeutic use.

References

Sources for this
clinical research guide.

These references underpin the evidence stages, study protocols and limits on claims discussed in this guide. Related reading is available in our News section.

[1]

Biology of AgingNational Institute on Aging, NIH

[2]

The Hallmarks of AgingCell / PubMed Central — López-Otín et al.

[3]

The Mitochondrial Basis of AgingMolecular Cell / PubMed Central — Sun, Youle and Finkel

[4]

The Drug Development ProcessU.S. Food and Drug Administration

[5]

Step 3: Clinical ResearchU.S. Food and Drug Administration

[6]

The Basics: NIH Clinical Trials and YouNational Institutes of Health